- Israel orders Beirut residents to flee after Hezbollah targets Haifa area
- Davis, LeBron power Lakers over Pelicans as Celtics win in OT
- Trump and allies return to New York for UFC fights
- Hong Kong political freedoms in spotlight during bumper trial week
- Debt-saddled Laos struggles to tame rampant inflation
- Senna, Schumacher... Beganovic? Macau GP showcases future F1 stars
- India's vinyl revival finds its groove
- G20 tests Brazil's clout in Lula 3.0 era
- Over 20,000 displaced by gang violence in Haiti: UN agency
- Famed gymastics coach Bela Karolyi dies
- 'Break taboos': Josep Borrell wraps up time as EU's top diplomat
- Climate finance can be hard sell, says aide to banks and PMs
- Trump revives 'peace through strength,' but meaning up to debate
- New York auction records expected for a Magritte... and a banana
- Egypt's middle class cuts costs as IMF-backed reforms take hold
- Beirut businesses struggle to stay afloat under Israeli raids
- Dupont lauds France 'pragmatism' in tight New Zealand win
- Swiatek leads Poland into maiden BJK Cup semi-final
- Trump taps fracking magnate and climate skeptic as energy chief
- West Indies restore pride with high-scoring win over England
- Hull clings to one-shot lead over Korda, Zhang at LPGA Annika
- Xi tells Biden ready for 'smooth transition' to Trump
- Trump nominates fracking magnate and climate skeptic as energy secretary
- Tyson says 'no regrets' over loss for fighting 'one last time'
- Springboks' Erasmus hails 'special' Kolbe after England try double
- France edge out New Zealand in Test thriller
- Xi tells Biden will seek 'smooth transition' in US-China ties
- Netherlands into Nations League quarter-finals as Germany hit seven
- Venezuela to free 225 detained in post-election unrest: source
- Late Guirassy goal boosts Guinea in AFCON qualifying
- Biden arrives for final talks with Xi as Trump return looms
- Dominant Sinner cruises into ATP Finals title decider with Fritz
- Dinosaur skeleton fetches 6 million euros in Paris sale
- Netherlands-Hungary Nations League match interrupted by medical emergency
- Kolbe double as South Africa condemn England to fifth successive defeat
- Kolbe at the double as South Africa condemn England to fresh defeat
- Kolbe at the double as South Africa beat England 29-20
- 'If I don't feel ready, I won't play singles,' says Nadal ahead of Davis Cup farewell
- Fifth of dengue cases due to climate change: researchers
- Trump's Republican allies tread lightly on Paris pact at COP29
- Graham equals record as nine-try Scotland see off tenacious Portugal
- Protesters hold pro-Palestinian march in Rio ahead of G20
- Graham equals record as nine-try Scotland see off dogged Portugal
- China's Xi urges APEC unity in face of 'protectionism'
- Japan's Kagiyama, Yoshida sweep gold in Finland GP
- Macron to press Milei on climate action, multilateralism in Argentina talks
- Fritz reaches ATP Finals title decider with Sampras mark in sight
- All eyes on G20 for breakthrough as COP29 climate talks stall
- Fritz battles past Zverev to reach ATP Finals title decider
- Xi, Biden to meet as Trump return looms
Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
E.Rodriguez--AT